Quote:

---

Someone posted over on StockTwits that it is possible to get approval after a phase II if results are stellar and they also stated that a large portion of drugs that had been approved after a phase II in the past few years were cancer drugs.

Any idea what our results would have to be in order to get approved based on this trial and do you think we'll be anywhere close to achieving those results?

---

The smaller number of patients in the trial would make approval tougher with a phase 2. It's possible but we might need a 50% or more improvement to get conditional approval. Which leronlimab might be capable of but the variability of patient condition with 60 patients could work for or against us.